UNITEDHEALTH GROUP INC (UNH) Form 8-K — Oct 13, 2026
UnitedHealth Group reported third quarter 2026 revenues of $112.7 billion and earnings from operations of $6.6 billion, with diluted EPS of $4.56 versus $2.59 a year ago and adjusted EPS of $4.69 versus $2.92. Earnings from operations rose 52% year-over-year on medical cost management, pricing discipline, and a medical care ratio improvement to 88.4% from 89.9%. The company raised full-year 2026 guidance to GAAP earnings of at least $19.50 per share and adjusted earnings of at least $20.50 per share. Cash flows from operations were $5.1 billion (1.2x net income), and the debt-to-capital ratio stood at 41.7%, with a long-term target of approximately 40% by year-end.
Key figures
- Eps
- 4.56
- Revenue
- 112694000000
- Guidance
- Full year 2026 GAAP EPS of at least $19.50; adjusted EPS of at least $20.50
- Net Income
- 4110000000
- Total Assets
- 312782000000
- Cash Position
- 28549000000
- Shares Outstanding
- 902000000
- Adjusted eps
- 4.69
- Ytd buybacks
- $5.0 billion
- Optum revenue
- $66.9 billion
- Ytd dividends
- $6.2 billion
- Members served
- 48.3 million
- Optum earnings
- $3.7 billion
- Debt to capital
- 41.7%
- Medical cost ratio
- 88.4% vs 89.9% year-ago
- Operating cost ratio
- 12.8% vs 13.5% year-ago
- Earnings from operations
- $6.6 billion
- Unitedhealthcare revenue
- $86.3 billion
- Optum rx adjusted scripts
- 393 million vs 414 million year-ago
- Unitedhealthcare earnings
- $2.8 billion
- Cash flows from operations
- $5.1 billion (1.2x net income)
- Favorable reserve development
- $610 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.